Crescent Capital BDC, Inc. filed its Form 10-Q with the U.S. Securities and Exchange Commission covering the quarterly period ended June 30, 2026, disclosing consolidated financial statements and related notes for the business development company.

Key Highlights

  • Filing period: Quarterly report covers the three and six months ended June 30, 2026.
  • Non-controlled non-affiliated investments: Carried at fair value of $1,485,083 thousand as of June 30, 2026, against a cost of $1,523,372 thousand.
  • Non-controlled affiliated investments: Reported at fair value of $31,053 thousand, with a cost basis of $30,445 thousand as of June 30, 2026.
  • Controlled investments: Carried at fair value of $54,532 thousand as of June 30, 2026, versus a cost of $71,244 thousand.
  • Cash and cash equivalents: Reported at $15,604 thousand as of June 30, 2026, compared with $5,043 thousand as of December 31, 2025.
  • Restricted cash and cash equivalents: Totaled $20,137 thousand as of June 30, 2026, down from $26,454 thousand as of December 31, 2025.
  • Shares outstanding: 36,845,952 shares of common stock were outstanding as of August 10, 2026, according to the filing.

Crescent Capital BDC Balance Sheet Snapshot as of June 30, 2026

Crescent Capital BDC, Inc. (NASDAQ: CCAP) is a Maryland-incorporated business development company managed by an external investment adviser and headquartered in Los Angeles, California. The company primarily invests in debt and other securities of middle-market companies, and its portfolio is categorized across non-controlled non-affiliated, non-controlled affiliated, and controlled investment classifications, each reported at fair value in the consolidated financial statements.

According to the filing, non-controlled non-affiliated investments, which represent the largest portion of the portfolio, stood at a fair value of $1,485,083 thousand against a cost of $1,523,372 thousand as of June 30, 2026. By comparison, as of December 31, 2025, that same category was carried at a fair value of $1,479,473 thousand against a cost of $1,504,658 thousand. The controlled investments category showed a fair value of $54,532 thousand relative to a cost of $71,244 thousand, while non-controlled affiliated investments were valued at $31,053 thousand against a cost of $30,445 thousand, the filing stated.

The registrant reported cash and cash equivalents of $15,604 thousand and restricted cash and cash equivalents of $20,137 thousand as of June 30, 2026. Interest and dividend receivable was disclosed at $8,214 thousand, and receivable from unsettled transactions stood at $716 thousand. The filing notes that it contains forward-looking statements that "are not historical facts" and are subject to risks and uncertainties, and the company cautioned that such statements "should not be regarded as a representation" that plans and objectives will be achieved.

What Was Disclosed

Crescent Capital BDC, Inc. filed its 10-Q for the quarter ended June 30, 2026, reporting consolidated asset and liability figures, investment fair values across three portfolio categories, and cash positions, as well as forward-looking statement disclosures subject to the company's cautionary language.